Related Experiment Video
Updated: Aug 11, 2025

Assessment and Evaluation of the High Risk Neonate: The NICU Network Neurobehavioral Scale
Published on: August 25, 2014
Prenatal Opioid Exposure and Neurodevelopmental Outcomes
Jennifer J Lee1, Neeta Saraiya1, Michael W Kuzniewicz2,3
1Department of Anesthesiology, Columbia University Irving Medical Center, New York, NY.
Prenatal opioid exposure may negatively impact infant neurodevelopment, causing cognitive and psychomotor deficits. More research is needed to understand long-term effects and confounding factors in neonatal opioid withdrawal syndrome.
Area of Science:
- Neuroscience
- Developmental Psychology
- Public Health
Background:
- The opioid epidemic has increased opioid use disorder in pregnant women, leading to more cases of neonatal opioid withdrawal syndrome.
- Long-term neurodevelopmental consequences of prenatal opioid exposure remain poorly understood.
- Existing human studies are limited by small sample sizes and confounding factors.
Approach:
- This review synthesizes current literature on prenatal opioid exposure and neurodevelopmental outcomes.
- It identifies gaps in knowledge and discusses confounding variables.
- It highlights considerations for future research.
Key Points:
- Animal studies suggest in-utero opioid exposure can cause increased neuronal apoptosis and reduced neuronal proliferation and myelination.
- Human studies indicate potential deficits in infant cognition, psychomotor performance, and preschool-level cognition and language.
- Confounding factors like polysubstance abuse, inadequate prenatal care, and home environment significantly complicate outcome assessment.
Conclusions:
- Further research is crucial to elucidate the precise neurodevelopmental trajectory of infants exposed to opioids prenatally.
- Future studies must address limitations of prior research, including controlling for confounding variables.
- A comprehensive understanding is needed to improve interventions and support for affected children and families.
More Related Videos
05:13Preclinical Model of Prenatal Delta-9-Tetrahydrocannabinol Exposure to Assess Its Impact on Neurodevelopmental Outcomes
Published on: February 28, 2025
15:27Construction of Vapor Chambers Used to Expose Mice to Alcohol During the Equivalent of all Three Trimesters of Human Development
Published on: July 13, 2014
Related Concept Videos
Teratogenicity
Factors Affecting Drug Response: Overview
Attention-Deficit/Hyperactivity Disorder
Diagnostic Criteria and Symptoms
To diagnose ADHD, symptoms must manifest before age 12 and be evident across multiple settings....